Medicines Co (MDCO) Reports Q2 Adj-EPS of 46c
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Income before income taxes: -86.2M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Financial Fact:
Income before income taxes: -86.2M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Medicines Co (NASDAQ: MDCO) reported Q2 adj-EPS of $0.46, GAAP EPS were $0.25, vs. the analyst estimate of $0.17. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $131.78 million.
For earnings history and earnings-related data on Medicines Co (MDCO) click here.
For earnings history and earnings-related data on Medicines Co (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Starts Lloyds TSB Group (LYG) at Hold, 'shares are fairly valued'
- Meta Platforms Inc. (META) PT Lowered to $500 at Goldman Sachs, 'Management Track Record of Execution Leaves Us Long-Term Constructive'
- STMicroelectronics cuts outlook as slower demand causes Q1 miss
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
